Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
L Ghosn, R Assi, T Evrenoglou… - Cochrane database …, 2023 - cochranelibrary.com
Background It has been reported that people with COVID‐19 and pre‐existing
autoantibodies against type I interferons are likely to develop an inflammatory cytokine storm …
autoantibodies against type I interferons are likely to develop an inflammatory cytokine storm …
[HTML][HTML] Complete blood count alterations in COVID-19 patients: A narrative review
M Palladino - Biochemia medica, 2021 - hrcak.srce.hr
Sažetak Coronavirus disease 2019 (COVID-19) pandemic represents a scientific and social
crisis. One of the main unmet needs for coronavirus disease 2019 is its unpredictable …
crisis. One of the main unmet needs for coronavirus disease 2019 is its unpredictable …
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
BJ Ward, P Gobeil, A Séguin, J Atkins, I Boulay… - Nature medicine, 2021 - nature.com
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being
deployed, but the global need greatly exceeds the supply, and different formulations might …
deployed, but the global need greatly exceeds the supply, and different formulations might …
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
Background High-flow nasal cannula (HFNC) has become a frequently used noninvasive
form of respiratory support in acute settings; however, evidence supporting its use has only …
form of respiratory support in acute settings; however, evidence supporting its use has only …
Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients
Z Sun, ZG Song, C Liu, S Tan, S Lin, J Zhu, FH Dai… - BMC medicine, 2022 - Springer
Background COVID-19 is an infectious disease characterized by multiple respiratory and
extrapulmonary manifestations, including gastrointestinal symptoms. Although recent …
extrapulmonary manifestations, including gastrointestinal symptoms. Although recent …
Clinical characteristics and outcomes of patients with COVID-19–associated acute respiratory distress syndrome who underwent lung transplant
C Kurihara, A Manerikar, M Querrey, C Felicelli… - Jama, 2022 - jamanetwork.com
Importance Lung transplantation is a potentially lifesaving treatment for patients who are
critically ill due to COVID-19–associated acute respiratory distress syndrome (ARDS), but …
critically ill due to COVID-19–associated acute respiratory distress syndrome (ARDS), but …
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
H Jing, X Wu, M Xiang, L Liu, VA Novakovic… - Frontiers in …, 2022 - frontiersin.org
COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …
Fast response humidity sensor based on hyperbranched zwitterionic polymer for respiratory monitoring and non-contact human machine interface
Y Yang, J Wang, J Lou, H Yao, C Zhao - Chemical Engineering Journal, 2023 - Elsevier
Non-contact humidity sensing is a prospective method for gathering biomedical information
and realizing the non-screen-contact human–machine interaction. However, humidity …
and realizing the non-screen-contact human–machine interaction. However, humidity …
Cellular immune response to COVID-19 and potential immune modulators
X Zhou, Q Ye - Frontiers in Immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …
Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26. COV2. S vaccines
JD Kelly, S Leonard, KJ Hoggatt, WJ Boscardin… - Jama, 2022 - jamanetwork.com
Importance Evidence describing the incidence of severe COVID-19 illness following
vaccination and booster with BNT162b2, mRNA-1273, and Ad26. COV2. S vaccines is …
vaccination and booster with BNT162b2, mRNA-1273, and Ad26. COV2. S vaccines is …